IDEVAX

Startup

Idevax is an ISO13845 certified Belgian medical device company specialising in innovative drug delivery solutions for prophylactic and therapeutic vaccine applications. Our flagship product line, VAX-ID®, is a CE-marked device suited for reliable, standardized, and user-independent skin drug delivery with minimal training and high degree of ease of use. FDA and WHO PQ are expected early 2026.  

VAX-ID® is designed to support a broad spectrum of applications, including preventive vaccines like Rabies, Mpox, Polio, HPV as well as immunotherapies and cancer vaccines. With its unique ability to consistently deliver into the dermis, it offers important advantages such as supporting solid immunogenicity, dose-sparing strategies, and equitable access to vaccines.  

 At Idevax, we are dedicated to empowering researchers, clinicians, and industry stakeholders including NGOs, biotechs, big pharma and KOLs, in their mission to develop and deploy life-changing therapies.  

Visit our website or follow our LinkedIn page to discover how Idevax’s innovative solutions are driving the future of biologics and improving patient outcomes worldwide. We look forward to connecting with you at the World Vaccine Conference 2025 in Amsterdam—let’s shape the future of vaccination together!  

website